HAL will be down for maintenance from Friday, June 10 at 4pm through Monday, June 13 at 9am. More information
Skip to Main content Skip to Navigation
Conference papers

Evaluation of biosafety of equine amniotic membranes for allogeneic use – a pilot study using PCR pathogens screening on peripheric maternal blood and paired fetal adnexa

Abstract : Transplantation of amniotic membranes (AM) is increasingly used for equine tissue reconstruction. However, there is currently no published data on systematic screening of donor mares for infectious diseases, in contrast to human medicine. To minimize the risk of iatrogenic donor‐borne contamination, we questioned the biosafety of equine AM. We hypothesized that the processed amnion layer of AM is less exposed than peripheric maternal blood (PMB) to pathogens, aiming to assess the risk of vertical contamination of AM from mares potentially carrying common equine infectious agents. The study was conducted on 6 fetal membrane collections during foaling seasons 2016–2017. Systematic Coggins test and PCR screening for B. caballi, T. equi, A. phagocytophilum, B. burgdorferi, Leptospira spp, Mycoplasma spp, R. equi, equine arteritis virus, equine herpesviruses type 1, 2, 4 and 5 were performed on PMB. The amnion layer was isolated, processed and frozen down at −80°C. Mycoplasma PCR screening and bacteriological and fungal cultures were performed to exclude environmental contamination. In case of one or more positive PCR result(s) on PMB, a PCR analysis for the detected pathogen(s) was conducted on a biopsy sample of the associated AM. All PMB samples were PCR positive for at least one pathogen: 3 for EHV2, 3 for EHV2 and EHV5. All AM samples were negative for these specific pathogens. In conclusion of this pilot study, processed equine AM appear free of donor‐borne contamination, even for vertically communicable pathogens such as gammaherpesviruses. More data is needed to assess the residual risk of contamination of amnion tissue when the mare is positive for one or more infectious agent(s). Also, emerging pathogens like hepaciviruses should be included in the future.
Document type :
Conference papers
Complete list of metadata

https://hal-normandie-univ.archives-ouvertes.fr/hal-02418894
Contributor : Erika Hue Connect in order to contact the contributor
Submitted on : Thursday, December 19, 2019 - 10:59:45 AM
Last modification on : Wednesday, March 9, 2022 - 12:00:03 PM

Identifiers

  • HAL Id : hal-02418894, version 1

Citation

M. Denys, Cédric Robert, N. Saulnier, Loïc Legrand, N. Plantier, et al.. Evaluation of biosafety of equine amniotic membranes for allogeneic use – a pilot study using PCR pathogens screening on peripheric maternal blood and paired fetal adnexa. 22th annual ESDAR Conference, Sep 2018, Cordoba, Spain. ⟨hal-02418894⟩

Share

Metrics

Record views

27